tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2024 Feb;30(2):245-254.
doi: 10.3201/eid3002.230863.
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021[SUP]1[/SUP]
Jessica Justman, Timothy Skalland, Ayana Moore, Christopher I Amos, Mark A Marzinke, Sahar Z Zangeneh, Colleen F Kelley, Rebecca Singer, Stockton Mayer, Yael Hirsch-Moverman, Susanne Doblecki-Lewis, David Metzger, Elizabeth Barranco, Ken Ho, Ernesto T A Marques, Margaret Powers-Fletcher, Patricia J Kissinger, Jason E Farley, Carrie Knowlton, Magdalena E Sobieszczyk, Shobha Swaminathan, Domonique Reed, Jean De Dieu Tapsoba, Lynda Emel, Ian Bell, Krista Yuhas, Leah Schrumpf, Laura Mkumba, Jontraye Davis, Jonathan Lucas, Estelle Piwowar-Manning, Shahnaz Ahmed; CoVPN 5002 COMPASS Study Team
During January-August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.
Keywords: 2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; community surveys; coronavirus disease; epidemiology; respiratory infections; severe acute respiratory syndrome coronavirus 2; surveys and questionnaires; time/location sampling; viruses; zoonoses.
. 2024 Feb;30(2):245-254.
doi: 10.3201/eid3002.230863.
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021[SUP]1[/SUP]
Jessica Justman, Timothy Skalland, Ayana Moore, Christopher I Amos, Mark A Marzinke, Sahar Z Zangeneh, Colleen F Kelley, Rebecca Singer, Stockton Mayer, Yael Hirsch-Moverman, Susanne Doblecki-Lewis, David Metzger, Elizabeth Barranco, Ken Ho, Ernesto T A Marques, Margaret Powers-Fletcher, Patricia J Kissinger, Jason E Farley, Carrie Knowlton, Magdalena E Sobieszczyk, Shobha Swaminathan, Domonique Reed, Jean De Dieu Tapsoba, Lynda Emel, Ian Bell, Krista Yuhas, Leah Schrumpf, Laura Mkumba, Jontraye Davis, Jonathan Lucas, Estelle Piwowar-Manning, Shahnaz Ahmed; CoVPN 5002 COMPASS Study Team
- PMID: 38270128
- DOI: 10.3201/eid3002.230863
During January-August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.
Keywords: 2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; community surveys; coronavirus disease; epidemiology; respiratory infections; severe acute respiratory syndrome coronavirus 2; surveys and questionnaires; time/location sampling; viruses; zoonoses.